Stockreport

Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF Acasti Pharma Inc. (NASDAQ: ACST Company Participants David Waldman - IR Jan D’Alvise - President and CEO Pierre Lemieux - COO, Chief Scientific Officer and Co-Founder B [Read more]